Cinacalcet

CAS No. 226256-56-0

Cinacalcet( AMG 073 | AMG073 | AMG-073 )

Catalog No. M13617 CAS No. 226256-56-0

A calcimimetic agent that acts as an allosteric activator of CaSR.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 Get Quote
25MG 58 Get Quote
50MG 72 Get Quote
100MG 132 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cinacalcet
  • Note
    Research use only, not for human use.
  • Brief Description
    A calcimimetic agent that acts as an allosteric activator of CaSR.
  • Description
    A calcimimetic agent that acts as an allosteric activator of CaSR; increases the concentration of cytoplasmic Ca(2+) in human embryonic kidney 293 cells expressing the human parathyroid CaR with EC50 of 51 nM; decreases PTH secretion from cultured bovine parathyroid cells with IC50 of 28 nM; is used for the treatment of tertiary hyperparathyroidism.Hyperparathyroidism Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AMG 073 | AMG073 | AMG-073
  • Pathway
    GPCR/G Protein
  • Target
    CaSR
  • Recptor
    CaSR
  • Research Area
    Endocrinology
  • Indication
    Hyperparathyroidism

Chemical Information

  • CAS Number
    226256-56-0
  • Formula Weight
    357.412
  • Molecular Formula
    C22H22F3N
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
  • Chemical Name
    1-Naphthalenemethanamine, .alpha.-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, (.alpha.R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nemeth EF, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):627-35. 2. Lindberg JS, et al. Kidney Int. 2003 Jan;63(1):248-54. 3. Quarles LD, et al. J Am Soc Nephrol. 2003 Mar;14(3):575-83.
molnova catalog
related products
  • Strontium ranelate

    A strontium(II) salt of ranelic acid that stimulates CaSR and leads to the differentiation of pre-osteoblast to osteoblast, increases the bone formation; also stimulates osteoblasts to secrete osteoprotegerin in inhibiting osteoclasts formed from pre-osteoclasts in relation to the RANKL system.

  • NPS-2143

    A potent, selective and orally active CaSR antagonist with IC50 of 43 nM.

  • AC-265347

    AC-265347 is a calcimimetic acting agent and highly efficacious, orally active allosteric agonist (PAM) of CaSR with IC50 of 10 nM in PI hydrolysis assays.